Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett’s esophagus to adenocarcinoma
- 1 January 2006
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (6) , 928-934
- https://doi.org/10.3748/wjg.v12.i6.928
Abstract
AIM: To investigate the expression of cyclooxygenase-2 (COX-2) and epithelial growth factor receptor (EGFR) throughout the progression of Barrett’s esophagus (BE).Keywords
This publication has 43 references indexed in Scilit:
- Simultaneously Targeting Epidermal Growth Factor Receptor Tyrosine Kinase and Cyclooxygenase-2, an Efficient Approach to Inhibition of Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2004
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- The Inflammation Hypothesis of AgingAnnals of the New York Academy of Sciences, 2001
- The Hallmarks of CancerCell, 2000
- Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the EsophagusThe American Journal of Pathology, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouseCell, 1995
- Strain-Dependent Epithelial Defects in Mice Lacking the EGF ReceptorScience, 1995
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990